Page last updated: 2024-10-20

spermine and ER-Negative PR-Negative HER2-Negative Breast Cancer

spermine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Fahrmann, JF1
Vykoukal, J1
Fleury, A1
Tripathi, S1
Dennison, JB1
Murage, E1
Wang, P1
Yu, CY1
Capello, M1
Creighton, CJ1
Do, KA1
Long, JP1
Irajizad, E1
Peterson, C1
Katayama, H1
Disis, ML1
Arun, B1
Hanash, S1
Batista de Carvalho, AL1
Pilling, M1
Gardner, P1
Doherty, J1
Cinque, G1
Wehbe, K1
Kelley, C1
Batista de Carvalho, LA1
Marques, MP1

Other Studies

2 other studies available for spermine and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Association Between Plasma Diacetylspermine and Tumor Spermine Synthase With Outcome in Triple-Negative Breast Cancer.
    Journal of the National Cancer Institute, 2020, 06-01, Volume: 112, Issue:6

    Topics: Animals; Chromatography, Liquid; Female; Gene Expression; Humans; Mice; Mice, Transgenic; Neoplasm M

2020
Chemotherapeutic response to cisplatin-like drugs in human breast cancer cells probed by vibrational microspectroscopy.
    Faraday discussions, 2016, 06-23, Volume: 187

    Topics: Antineoplastic Agents; Biomarkers; Cell Line, Tumor; Cisplatin; Humans; Spectrophotometry, Infrared;

2016